Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
FEBS Letters|April 24, 1990
The antioxidant action of tamoxifen and its metabolites. Inhibition of lipid peroxidationH Wiseman, M J Laughton, H R Arnstein, et al.
Inflammopharmacology|September 26, 2008
Health benefits of isoflavones in functional foods? Proteomic and metabonomic advancesM C Y Wong, P W Emery, V R Preedy, et al.
Obstetrics and Gynecology|September 1, 1986
Trend associations of smoking with maternal, fetal, and neonatal morbidityC Hoff, W Wertelecki, W R Blackburn, et al.
Nutrition and Cancer|May 8, 2000
Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microfloraI R Rowland, H Wiseman, T A Sanders, et al.
Psychopharmacology|October 18, 2001
Eating soya improves human memoryS E File, N Jarrett, E Fluck, et al.
Cancer Letters|September 14, 1992
Droloxifene (3-hydroxytamoxifen) has membrane antioxidant ability: potential relevance to its mechanism of therapeutic action in breast cancerH Wiseman, C Smith, B Halliwell, et al.
Circulation|December 16, 1998
Presence of angiographic coronary collaterals predicts myocardial recovery after coronary bypass surgery in patients with severe left ventricular dysfunctionH Kozman, J R Cook, A H Wiseman, et al.
Frontiers in Cell and Developmental Biology|March 29, 2021
The Dynamic Interface Between the Bone Marrow Vascular Niche and Hematopoietic Stem Cells in Myeloid MalignancyLaura Mosteo, Joanna Storer, Kiran Batta, et al.
Medicinal Research Reviews|November 25, 2014
Reversible inhibitors of LSD1 as therapeutic agents in acute myeloid leukemia: clinical significance and progress to dateDaniel P Mould, Alison E McGonagle, Daniel H Wiseman, et al.
Analytical Biochemistry|August 6, 2013
CD86 expression as a surrogate cellular biomarker for pharmacological inhibition of the histone demethylase lysine-specific demethylase 1James T Lynch, Mark J Cockerill, James R Hitchin, et al.
Pageof 10